These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 31978441)

  • 1. Emerging nanomedicine-based strategies for preventing metastasis of pancreatic cancer.
    Li YJ; Wu JY; Wang JM; Xiang DX
    J Control Release; 2020 Apr; 320():105-111. PubMed ID: 31978441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology-integrated ovarian cancer metastasis therapy: Insights from the metastatic mechanisms into administration routes and therapy strategies.
    Huang Y; Li C; Zhang X; Zhang M; Ma Y; Qin D; Tang S; Fei W; Qin J
    Int J Pharm; 2023 Apr; 636():122827. PubMed ID: 36925023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomedicine Strategies to Enhance Tumor Drug Penetration in Pancreatic Cancer.
    Lu T; Prakash J
    Int J Nanomedicine; 2021; 16():6313-6328. PubMed ID: 34552327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reviewing two decades of nanomedicine implementations in targeted treatment and diagnosis of pancreatic cancer: An emphasis on state of art.
    El-Zahaby SA; Elnaggar YSR; Abdallah OY
    J Control Release; 2019 Jan; 293():21-35. PubMed ID: 30445002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal barriers to nanomedicine penetration in the pancreatic tumor microenvironment.
    Tanaka HY; Kano MR
    Cancer Sci; 2018 Jul; 109(7):2085-2092. PubMed ID: 29737600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH-sensitive nano-systems for drug delivery in cancer therapy.
    Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
    Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging nanomedicine approaches fighting tumor metastasis: animal models, metastasis-targeted drug delivery, phototherapy, and immunotherapy.
    Liang C; Xu L; Song G; Liu Z
    Chem Soc Rev; 2016 Nov; 45(22):6250-6269. PubMed ID: 27333329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomedicine as a multimodal therapeutic paradigm against cancer: on the way forward in advancing precision therapy.
    Sandbhor P; Palkar P; Bhat S; John G; Goda JS
    Nanoscale; 2024 Mar; 16(13):6330-6364. PubMed ID: 38470224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phytochemical-Based Nanomedicine for Targeting Tumor Microenvironment and Inhibiting Cancer Chemoresistance: Recent Advances and Pharmacological Insights.
    Sa P; Mohapatra P; Swain SS; Khuntia A; Sahoo SK
    Mol Pharm; 2023 Nov; 20(11):5254-5277. PubMed ID: 37596986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicine for overcoming therapeutic and diagnostic challenges associated with pancreatic cancer.
    Iyengar D; Tatiparti K; Gavande NS; Sau S; Iyer AK
    Drug Discov Today; 2022 Jun; 27(6):1554-1559. PubMed ID: 35247592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging nanomedicine-based therapeutics for hematogenous metastatic cascade inhibition: Interfering with the crosstalk between "seed and soil".
    Wu J; Long Y; Li M; He Q
    Acta Pharm Sin B; 2021 Aug; 11(8):2286-2305. PubMed ID: 34522588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances of nanomedicines in breast cancer metastasis treatment targeting different metastatic stages.
    Yu W; Hu C; Gao H
    Adv Drug Deliv Rev; 2021 Nov; 178():113909. PubMed ID: 34352354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Nanotechnology in Preclinical Pancreatic Cancer Immunotherapy: Driving Towards Clinical Applications.
    Pan X; Han T; Zhao Z; Wang X; Fang X
    Int J Nanomedicine; 2024; 19():6619-6641. PubMed ID: 38975321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges and Opportunities from Basic Cancer Biology for Nanomedicine for Targeted Drug Delivery.
    Xie X; Zhang Y; Li F; Lv T; Li Z; Chen H; Jia L; Gao Y
    Curr Cancer Drug Targets; 2019; 19(4):257-276. PubMed ID: 29956629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bridging Bio-Nano Science and Cancer Nanomedicine.
    Björnmalm M; Thurecht KJ; Michael M; Scott AM; Caruso F
    ACS Nano; 2017 Oct; 11(10):9594-9613. PubMed ID: 28926225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxic Tumor-Derived Exosomal miR-301a Mediates M2 Macrophage Polarization via PTEN/PI3Kγ to Promote Pancreatic Cancer Metastasis.
    Wang X; Luo G; Zhang K; Cao J; Huang C; Jiang T; Liu B; Su L; Qiu Z
    Cancer Res; 2018 Aug; 78(16):4586-4598. PubMed ID: 29880482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remodeling tumor microenvironment with nanomedicines.
    Martin JD; Miyazaki T; Cabral H
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Nov; 13(6):e1730. PubMed ID: 34124849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined cancer therapeutics-Tackling the complexity of the tumor microenvironment.
    Roma-Rodrigues C; Raposo LR; Valente R; Fernandes AR; Baptista PV
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1704. PubMed ID: 33565269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomedicines Targeting the Tumor Microenvironment.
    Tong R; Langer R
    Cancer J; 2015; 21(4):314-21. PubMed ID: 26222084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway.
    Zhang L; Wang D; Li Y; Liu Y; Xie X; Wu Y; Zhou Y; Ren J; Zhang J; Zhu H; Su Z
    PLoS One; 2016; 11(8):e0158529. PubMed ID: 27505247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.